The hunt is on and a predator finally zeroes in on its prey. The animal consumes the nutritious meal and moves on to forage ...

Massif Capital's Q3 2025 Real Assets Strategy returned 36.1% net, YTD 41.5%, with strong Alpha and Sortino. Discusses gold, ...

Although Kimberly-Clark suffered a huge blow after announcing its Kenvue buyout, KMB stock is flashing a quantitative ...

The RunStar 8E SmartScan Pro Body Fat Scale not only tracks over 21 body composition stats, but can also measure the ...

Moody's remains a strong investment pick with robust earnings, recurring revenues, and resilience against emerging market and ...

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2025 financial results.

Objectives There is a lack of knowledge about whether occupational exposures increase the risk of emphysema, especially in ...

Over the last few years, the narrative around the outlook for decarbonization has been predominately negative. The ...

Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...

The Company continues to enroll in Cohort 3 of CORAL-1, the Company’s multi-center, dose escalation study evaluating KB407 in patients with CF, regardless of their underlying genotype, and expects to ...

If you've been investing for a while and paid attention to any income dropped into your account, you probably have a decent ...